Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

NCT00087737 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: DVS-233 SR
DRUG: Venlafaxine ER

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer